For treatment-naïve and treatment-experienced liver transplant recipients without cirrhosis or with compensated cirrhosis (Child-Pugh A), the recommended regimen is EPCLUSA once daily for 12 weeks [see Clinical Studies (14.3 and 14.5)].

EPCLUSA (sofosbuvir 400 mg/velpatasvir 100 mg, 200 mg/50 mg tablets; 200 mg/50 mg, 150 mg/37.5 mg oral pellets) is indicated for the treatment of patients 3 years of age and older with chronic hepatitis C virus (HCV) genotype 1-6 infection without cirrhosis or with compensated cirrhosis and in combination with ...

Generic Name: sofosbuvir-velpatasvir These drugs work by reducing the amount of hepatitis C virus in your body, which helps your immune system fight the infection and may help your liver recover. Chronic hepatitis C infection can cause serious liver problems such as scarring (cirrhosis), or liver cancer.

If Epclusa is prescribed with ribavirin, follow your doctor's recommendations for ribavirin dosing. In studies, 95% to 99% of Epclusa-treated patients without cirrhosis or with mild cirrhosis had no virus detected in the blood 12 weeks after finishing the 12-week regimen.

* Certain patients were cured with just 8 weeks of therapy. † Cure means the Hep C virus is not detected in the blood when measured three months after treatment is completed. Like HARVONI, EPCLUSA (sofosbuvir 400 mg/velpatasvir 100 mg) is a clear step forward in Hep C treatment.

EPCLUSA's 98% overall cure rate is based on studies of genotype 1-6 patients without cirrhosis or with compensated cirrhosis.

EPCLUSA's 98% overall cure rate is based on studies of genotype 1-6 patients without cirrhosis or with compensated cirrhosis.

Epclusa® is a brand of sofosbuvir and velpatasvir that comes in a tablet form. This antiviral medication treats hepatitis C.

EPCLUSA can cause serious side effects, including: If you have ever had hepatitis B, the hepatitis B virus could become active again during and after treatment with EPCLUSA. This may cause serious liver problems including liver failure and death.

You may be wondering how long you have to take Epclusa to treat hepatitis C. You'll likely take the drug once daily for 12 weeks. This is the amount of time it takes for Epclusa to clear the hepatitis C virus from your body.

* Certain patients were cured with just 8 weeks of therapy. † Cure means the Hep C virus is not detected in the blood when measured three months after treatment is completed. Like HARVONI, EPCLUSA (sofosbuvir 400 mg/velpatasvir 100 mg) is a clear step forward in Hep C treatment.

You may be wondering how long you have to take Epclusa to treat hepatitis C. You'll likely take the drug once daily for 12 weeks. This is the amount of time it takes for Epclusa to clear the hepatitis C virus from your body.